Home > Qtrly Results > GLENMARK LIFE SCIENCES

GLENMARK LIFE SCIENCES
Quarterly Results Analysis [Mar2024]

GLENMARK LIFE SCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLENMARK LIFE SCIENCES
Please provide your vote to see the results

GLENMARK LIFE SCIENCES Quarterly Results

Standalone Mar2024
Audited
Dec2023
Audited
Sep2023
Audited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
Audited
Revenues ₹537 Cr ₹573 Cr ₹595 Cr ₹578 Cr ₹621 Cr ₹541 Cr ₹509 Cr ₹490 Cr
Expenses ₹395 Cr ₹400 Cr ₹428 Cr ₹385 Cr ₹415 Cr ₹395 Cr ₹366 Cr ₹343 Cr
Operating Income ₹141 Cr ₹173 Cr ₹167 Cr ₹193 Cr ₹206 Cr ₹145 Cr ₹144 Cr ₹147 Cr
Other Income ₹3 Cr ₹2 Cr ₹5 Cr ₹2 Cr ₹3 Cr ₹7 Cr ₹10 Cr ₹9 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹15 Cr ₹13 Cr ₹13 Cr ₹13 Cr ₹12 Cr ₹11 Cr ₹10 Cr ₹10 Cr
Profit Before Tax ₹130 Cr ₹161 Cr ₹159 Cr ₹182 Cr ₹198 Cr ₹141 Cr ₹144 Cr ₹146 Cr
Profit After Tax ₹98 Cr ₹119 Cr ₹119 Cr ₹135 Cr ₹146 Cr ₹105 Cr ₹107 Cr ₹109 Cr
EPS ₹7.99 ₹9.69 ₹9.69 ₹11.05 ₹11.95 ₹8.57 ₹8.72 ₹8.87
Industry Peers & Returns1W1M1Y
GLENMARK LIFE SCIENCES 0.2% 4.6% 53%
SUN PHARMACEUTICAL INDUSTRIES 2% -0.3% 59.8%
CIPLA 6% 2.8% 50.4%
DR REDDYS LABORATORIES -1.3% -2.8% 31.5%
ZYDUS LIFESCIENCES 2.6% 7.9% 94.3%
DIVIS LABORATORIES 3.7% 5.8% 17.3%
MANKIND PHARMA -6.5% -7.6% 57%
TORRENT PHARMACEUTICALS 3.9% 7.3% 60.6%
LUPIN 3.2% 3.3% 111.9%

GLENMARK LIFE SCIENCES Quarterly Revenues

Revenues
Q-o-Q

-6.32 %

Y-o-Y

-13.64 %

Quarters Revenues % Change
Mar2024 ₹537 Cr
-6.32
Dec2023 ₹573 Cr
-3.79
Sep2023 ₹595 Cr
2.92
Jun2023 ₹578 Cr
-6.90
Mar2023 ₹621 Cr
14.90
Dec2022 ₹541 Cr
6.17
Sep2022 ₹509 Cr
3.97
Jun2022 ₹490 Cr -

GLENMARK LIFE SCIENCES Quarterly Operating Profit

Operating Profit
Q-o-Q

-18.03 %

Y-o-Y

-31.48 %

Quarters Operating Profit % Change
Mar2024 ₹141 Cr
-18.03
Dec2023 ₹173 Cr
3.27
Sep2023 ₹167 Cr
-13.50
Jun2023 ₹193 Cr
-6.43
Mar2023 ₹206 Cr
41.92
Dec2022 ₹145 Cr
1.26
Sep2022 ₹144 Cr
-2.13
Jun2022 ₹147 Cr -
Operating Margins
Q-o-Q

-12.48 %

Y-o-Y

-20.65 %

Quarters Operating Margin% % Change
Mar2024 26.36%
-12.48
Dec2023 30.12%
7.34
Sep2023 28.06%
-15.96
Jun2023 33.39%
0.51
Mar2023 33.22%
23.49
Dec2022 26.9%
-4.61
Sep2022 28.2%
-5.87
Jun2022 29.96% -

GLENMARK LIFE SCIENCES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-17.54 %

Y-o-Y

-33.08 %

Quarters Profit After Tax % Change
Mar2024 ₹98 Cr
-17.54
Dec2023 ₹119 Cr
0.02
Sep2023 ₹119 Cr
-12.34
Jun2023 ₹135 Cr
-7.45
Mar2023 ₹146 Cr
39.40
Dec2022 ₹105 Cr
-1.76
Sep2022 ₹107 Cr
-1.71
Jun2022 ₹109 Cr -
PAT Margins
Q-o-Q

-11.96 %

Y-o-Y

-22.54 %

Quarters PAT Margin(%) % Change
Mar2024 18.25 %
-11.96
Dec2023 20.73 %
3.96
Sep2023 19.94 %
-14.86
Jun2023 23.42 %
-0.59
Mar2023 23.56 %
21.32
Dec2022 19.42 %
-7.48
Sep2022 20.99 %
-5.45
Jun2022 22.2 % -

GLENMARK LIFE SCIENCES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-17.54 %

Y-o-Y

-33.14 %

Quarters EPS % Change
Mar2024 ₹7.99
-17.54
Dec2023 ₹9.69
0.00
Sep2023 ₹9.69
-12.31
Jun2023 ₹11.05
-7.53
Mar2023 ₹11.95
39.44
Dec2022 ₹8.57
-1.72
Sep2022 ₹8.72
-1.69
Jun2022 ₹8.87 -

You may also like the below Video Courses